logo logo
  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
    • Vetted Prospectus
    • IPO Information
    • IPO Utilization Report
    • IPO Related Published News
  • PRODUCTS
    • Tablet
  • ANNUAL REPORTS
    • Annual Report
  • INVESTOR RELATIONS
    • Unclaimed / Unsettled Dividend
    • CG Compliance Status
    • Board of Directors
    • Director's Report
    • Quarterly Report
    • Audited Financial Statements
    • Dividend Distribution Policy
    • Code of Conduct
    • Annual General Meeting
    • PRICE SENSITIVE INFORMATION (PSI)
    • Code of Conduct
    • Corporate Brief
  • MEDIA
  • CAREER
  • WEBMAIL
  • LOGIN

Investor Relations

    Notice of the 5th Annual General Meeting (2018-2019) Proxy Form & Attendance Slip (2017-2018) Shareholders Information for Published Annual Report 2017-2018 Notice of the 4th Annual General Meeting (2017-2018_ Code of Conduct for the Chairperson, other Board members & CEO Dividend Distribution Policy Audited Financial statements for the year ended 30 June 2021 Audited Financial statements for the year ended 30 June 2020 Audited Financial statements for the year ended 30 June 2019 Audited Financial statements for the year ended 30 June 2018.
  • ‹
  • 1
  • 2
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ›
04312174811
04312174977
info@indo-banglapharma.com
Fax: +88-02-57164716 (Ext-101)

VISITOR COUNTER

2 3 2 0 2 4

Quick Links

  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
  • PRODUCTS
  • ANNUAL REPORTS

Quick Links

    • INVESTOR RELATIONS
    • MEDIA
    • CAREER
    • WEBMAIL
    • LOGIN

Copyright © 2025 Indo-Bangla Pharmaceuticals Limited

Develop By : Motaharul Islam